Cargando…
Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease
BACKGROUND: The paucity of SARS-CoV-2-specific virulence factors has greatly hampered the therapeutic management of patients with COVID-19 disease. Although available vaccines and approved therapies have shown tremendous benefits, the continuous emergence of new variants of SARS-CoV-2 and side effec...
Autores principales: | Ayass, Mohamad Ammar, Tripathi, Trivendra, Griko, Natalya, Pashkov, Victor, Dai, Jun, Zhang, Jin, Herbert, Fabian C., Ramankutty Nair, Ramya, Okyay, Tutku, Zhu, Kevin, Gassensmith, Jeremiah J., Abi-Mosleh, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800238/ https://www.ncbi.nlm.nih.gov/pubmed/36581924 http://dx.doi.org/10.1186/s12985-022-01943-7 |
Ejemplares similares
-
New High-Affinity Thrombin Aptamers for Advancing Coagulation Therapy: Balancing Thrombin Inhibition for Clot Prevention and Effective Bleeding Management with Antidote
por: Ayass, Mohamad Ammar, et al.
Publicado: (2023) -
Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system
por: Ayass, Mohamad Ammar, et al.
Publicado: (2022) -
Pathogenic Strains of Acanthamoeba Are Recognized by TLR4 and Initiated Inflammatory Responses in the Cornea
por: Alizadeh, Hassan, et al.
Publicado: (2014) -
A serological aptamer-assisted proximity ligation assay for COVID-19 diagnosis and seeking neutralizing aptamers
por: Liu, Ran, et al.
Publicado: (2020) -
Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing Antibodies
por: Muharemagic, Darija, et al.
Publicado: (2014)